(Q74079086)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

title

The effects of gliclazide and other sulfonylureas on low-density lipoprotein oxidation in vitro (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

R C O'Brien

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

M Luo

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

publication date

1 December 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

issue

12 Suppl 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

page(s)

22-25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

Diabetes mellitus and macrovascular complications. An epidemiological perspective

8 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Diabetes and Glucose Tolerance as Risk Factors for Cardiovascular Disease: The Framingham Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Catalysis of lipid peroxidation by glucose and glycosylated collagen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Abnormalities of ascorbic acid metabolism and diabetic control: differences between diabetic patients and diabetic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Gliclazide: a general free radical scavenger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Effects of gliclazide on platelet reactivity and free radicals in type II diabetic patients: Clinical assessment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

A rapid method for measurement of the susceptibility to oxidation of low-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

From hemobiology to vascular disease: a review of the potential of gliclazide to influence the pathogenesis of diabetic vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0026-0495%2897%2990312-7

10.1016/S0026-0495(97)90312-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9439554%20AND%20SRC:MED&resulttype=core&format=json

8 November 2019

1 reference